United States · FDA National Drug Code directory
atovaquone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-421_b221c446-0200-4c11-bd0c-ff9ec502bc19
- Product NDC
- 68462-421
- Form
- SUSPENSION
- Composition / generic term
- atovaquone
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171231
- Source listing expiry
- 20271231
Source-listed ingredients
- ATOVAQUONE — 750 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 210 mL in 1 BOTTLE (68462-421-21) · 68462-421-21
- 42 POUCH in 1 CARTON (68462-421-69) / 5 mL in 1 POUCH · 68462-421-69
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →